| PERIOD ENDING | 24-Oct-09 | 25-Jul-09 | 25-Apr-09 | 24-Jan-09 | | Total Revenue | 346,146 | 330,367 | 156,170 | 121,710 | | Cost of Revenue | 203,041 | 187,576 | 93,985 | 78,411 | | | Gross Profit | 143,105 | 142,791 | 62,185 | 43,299 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 86,445 | 88,252 | 76,530 | 73,283 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 56,660 | 54,539 | (14,345) | (29,984) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 10 | 135 | (612) | | Earnings Before Interest And Taxes | 56,660 | 54,549 | (14,210) | (30,596) | | Interest Expense | 7,738 | 7,560 | 4,439 | 4,304 | | Income Before Tax | 48,922 | 46,989 | (18,649) | (34,900) | | Income Tax Expense | 19,325 | 18,560 | (7,355) | (13,330) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 29,597 | 28,429 | (11,294) | (21,570) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 29,597 | 28,429 | (11,294) | (21,570) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $29,597 | $28,429 | ($11,294) | ($21,570) |
|
0.02% Nasdaq 0.00%
Income Statement
